926211-83-8

Usage

Uses

Used in Pharmaceutical Industry:
2-(3-Bromo-phenoxy)-ethylamine is utilized as an intermediate in the synthesis of various drugs and pharmaceutical products. Its unique structure allows it to be a key component in the development of new medications.
Used in Medicinal and Chemical Research:
As a compound with potential biological activity, 2-(3-Bromo-phenoxy)-ethylamine is studied for its role as a ligand for certain receptors and enzymes. This research could lead to advancements in understanding and treating various diseases and conditions.
Used in Organic Synthesis:
2-(3-Bromo-phenoxy)-ethylamine serves as a valuable building block in organic synthesis, enabling the creation of a wide range of chemical compounds for various applications across different industries.

Upstream product

• 951918-24-4 3-bromophenoxyacetonitrile 
• 1075177-90-0 2-(3-bromophenoxy)ethyl methanesulfonate 
• 79906-55-1 2-(3-bromo-phenoxy)-ethanol 
• 591-20-8 3-Bromophenol 
• 938642-05-8 N-(2-(3-Bromophenoxy)ethyl)phthalimide 

Downstream Products

• 1075177-91-1 C₁₀H₉BrF₃NO₂ 
• 1098107-95-9 2,2,2-trifluoro-N-(2-(3-(5-hydroxypent-1-ynyl)phenoxy)ethyl)acetamide 
• 1098106-89-8 2,2,2-trifluoro-N-(2-(3-((1-hydroxycyclopentyl)ethynyl)phenoxy)ethyl)acetamide 
• 1098106-88-7 2,2,2-trifluoro-N-(2-(3-(3-hydroxy-3-methylbut-1-ynyl)phenoxy)ethyl)acetamide 
• 1098104-50-7 4-((3-(2-aminoethoxy)phenyl)ethynyl)tetrahydro-2H-thiopyran-4-ol 
• 1098107-19-7 2,2,2-trifluoro-N-(3-(3-((4-hydroxytetrahydro-2H-thiopyran-4-yl)ethynyl)phenoxy)propyl)acetamide 
• 1098104-76-7 1-((3-(2-aminoethoxy)phenyl)ethynyl)cycloheptanol 
• 1098107-47-1 2,2,2-trifluoro-N-(2-(3-((1-hydroxycycloheptyl)ethynyl)phenoxy)ethyl)acetamide 
• 1098103-99-1 4-((3-(2-aminoethoxy)phenyl)ethynyl)heptan-4-ol trifluoroacetate 
• 1098106-70-7 C₁₉H₂₄F₃NO₃ 

Relevant academic research and scientific papers

2 - Phenoxyethylamine-cyclohexylsulfonamide compound as well as preparation method and application thereof

The invention belongs to the field of agricultural chemicals, and particularly relates to synthesis of N - (2 - trifluoromethyl -4 - chlorophenyl) -2 - phenoxyethyl cyclohexylsulfonamide compound and application of the compound as a bactericide. The compo

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.